Web Stats Provided By Google Analytics

Thursday, August 15, 2013

Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust...

Inovio Pharmaceuticals, Inc. announced today that its SynConA DNA vaccine containing multiple malaria antigens delivered via its CELLECTRAA electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates.

http://www.drugs.com/news/inovio-pharmaceuticals-malaria-dna-vaccine-demonstrates-robust-immune-responses-animal-models-46756.html?

No comments:

Post a Comment